Fermentalg (ALGAE.PA)
Fermentalg operates in the Biotechnology industry of the Healthcare sector, headquartered in Libourne, NA, FR. The stock last traded at $0.47, down 0.63% on the session, giving a market capitalisation of $56.7M. Its beta of 1.04 implies it has historically moved more than the broad market.
Fermentalg SA, established in 2009 and headquartered in Libourne, France, is an internationally operating company specializing in the research, manufacturing, and sale of functional ingredients sourced from microalgae. These offerings serve various industries, including food, health, nutritional supplements, and environmental protection. Their product portfolio features DHA ORIGINS, a plant-derived DHA oil; KALVEA PLUS, a high-protein algal concentrate tailored for aquaculture feed; Everzure, a naturally occurring, acid-stable blue colorant; BLUE ORIGINS AOX, known for its antioxidant and anti-inflammatory benefits; BLUE ORIGIN, another natural coloring agent; and advanced clean air solutions designed for industrial CO2 capture.
Fermentalg is most often compared with the following Healthcare names: